Capnocytophaga bacteraemia following rituximab treatment
- PMID: 22891017
- PMCID: PMC4543085
- DOI: 10.1136/bcr-2012-006224
Capnocytophaga bacteraemia following rituximab treatment
Abstract
A case is presented of Capnocytophaga bacteraemia, in a juvenile chronic arthritis (JCA) patient receiving steroids, methotrexate and rituximab. This Gram-negative bacillus commonly found in dog saliva has been described to cause illness in immune compromised hosts such as oncology patients, those receiving cytotoxic or biological drugs, alcoholics or postsplenectomy. To the best of our knowledge, this is the first report of Capnocytophaga bacteraemia following rituximab treatment.
References
-
- Lion C, Escande F, Burdin JC. Capnocytophaga canimorsus infections in humans: review of the literature and case reports. Eur J Epidemiol 1996;12:521–33. - PubMed
-
- Parenti DM, Snydman DR. Capnocytophaga species: infections in non-immunocompromised and immunocompromised hosts. J Infect Dis 1985;151:140–7. - PubMed
-
- Pers C, Gahrn-Hansen B, Frederiksen W. Capnocytophaga canimorsus septicemia in Denmark, 1982–1995: review of 39 cases. Clin Infect Dis 1996;23:71–5. - PubMed
-
- Decoster H, Snoeck J, Pattyn S. Capnocytophaga canimorsus endocarditis. Eur Heart J 1992;13:140–2. - PubMed
-
- Ngaage DL, Kotidis KN, Sandoe JA, et al. Do not snog the dog: infective endocarditis due to Capnocytophaga canimorsus. Eur J Cardiothorac Surg 1999;16:362–3. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources